Study guide
10.3 Continuation-in-Part (CIP) Applications & Priority Allocation
USPTO Registration Examination Patent Bar
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview, Registration & MPEP Structure
1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies
2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)
2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines
3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)
3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards
4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)
4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits
5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))
5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status
6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))
6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims
7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)
7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments
8 Chapter 8: Duty of Disclosure & Information Disclosure Statements
8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance
9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)
9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice
10 Chapter 10: Continuing Applications & Copendency
10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation
11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)
11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA
12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)
12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)
13 Chapter 13: Patent Term, Maintenance Fees & Ownership
13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156
14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)
14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371
15 Chapter 15: Special Patent Categories & Professional Conduct
15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips
16 Chapter 16: Security, Access, Representation & Filing Mechanics
16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures
17 Chapter 17: Restriction, Publication, Allowance & Office Authority
17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority
18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway
18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway
19 Chapter 19: AIA Trial Practice Under the Consolidated Guide
19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision
10.3 Continuation-in-Part (CIP) Applications & Priority Allocation
Key Takeaways Explain This Topic AI
A Continuation-in-Part (CIP) application is a continuing application filed during the lifetime of a parent nonprovisional application that repeats a substantial portion or all of the parent specification while adding new matter not present in the parent.
CIP applications operate under a dual priority scheme (split effective filing dates): claims fully supported by the parent specification under 35 U.S.C. § 112(a) get the parent's filing date, while claims reciting new matter get the CIP's actual filing date.
Prior art disclosures published between the parent filing date and the CIP filing date can invalidate CIP claims that rely on new matter, but cannot be cited against CIP claims fully supported by the parent.
Self-collision occurs when the parent application's own publication or issued patent acts as prior art against the CIP application's new matter claims if published more than one year prior to the CIP filing date (or under applicable AIA § 102 prior art rules).
The 20-year patent term for ALL claims in a CIP application is measured from the filing date of the earliest nonprovisional parent application claimed under 35 U.S.C. § 120, resulting in a shortened patent term for new-matter claims.
Last updated: August 2026
10.3 Continuation-in-Part (CIP) Applications & Priority Allocation
A Continuation-in-Part (CIP) application is a continuing patent application filed during the pendency of an earlier nonprovisional parent application that discloses subject matter repeating a substantial portion or all of the parent specification while introducing new matter (additional technical disclosure, enhancements, or modifications) not present in the parent disclosure. Governed by 35 U.S.C. § 120 , 37 C.F.R. § 1.78 , and MPEP § 201.08 , CIP applications allow inventors to refine and improve their technology while preserving earlier priority for original subject matter.
Unlike standard continuation or divisional applications—which strictly prohibit new matter—a CIP is explicitly designed to incorporate new technical disclosures developed after the parent filing date.
Statutory Requirements for CIP Filings
To qualify as a valid CIP application under 35 U.S.C. § 120, the application must meet three fundamental procedural criteria:
Copendency : Must be filed while the parent nonprovisional application is pending (before patent grant or abandonment).
Common Inventorship : Must share at least one common inventor with the parent application.
Reference in ADS : Must contain a specific reference claiming priority to the parent application in an Application Data Sheet (ADS) per 37 C.F.R. § 1.78.
The Dual Priority Allocation Scheme (Split Priority)
The most critical legal rule governing CIP applications on the Patent Bar exam is that claims within a single CIP application do NOT all receive the parent application's filing date . Instead, the USPTO applies a claim-by-claim dual priority allocation scheme based on written description and enablement support under 35 U.S.C. § 112(a) .
Claim Category Disclosure Support Requirement Effective Filing Date Assigned Prior Art Vulnerability
Parent-Supported Claims Fully supported by original parent specification under 35 U.S.C. § 112(a) Parent Application Filing Date (Date A) Immunized against prior art published between Date A and Date C
New Matter Claims Recites or relies upon new matter introduced in the CIP specification CIP Application Filing Date (Date C) Vulnerable to intervening prior art published between Date A and Date C
Claim-by-Claim Evaluation
An examiner evaluates each claim in a CIP individually. If a claim can be practiced solely using the teaching of the parent specification, it retains the parent's earlier filing date (Date A). If a claim includes even a single limitation that relies on the newly added disclosure for § 112(a) support, that entire claim receives the later CIP filing date (Date C).
Intervening Prior Art & Self-Collision Risks
Because new-matter claims receive the later CIP filing date (Date C), any prior art reference published, patented, or publicly disclosed between the parent filing date (Date A) and the CIP filing date (Date C)—known as intervening prior art —can be cited by the examiner under 35 U.S.C. § 102 or § 103 to reject the new-matter claims.
The Risk of Self-Collision (Parent as Prior Art)
A major trap in CIP practice is self-collision . When a parent application publishes (as a U.S. Patent Application Publication) or issues as a patent prior to the filing of the CIP application, the parent's disclosure becomes public.
For parent-supported claims in the CIP, the parent publication is not prior art because the claims share the parent's effective filing date.
For new-matter claims in the CIP, the parent's published specification CAN be cited as prior art against the CIP claims if it qualifies as prior art under 35 U.S.C. § 102 (for example, if the parent published more than one year prior to the CIP filing date under pre-AIA law, or qualifies under AIA § 102(a)(1) without an exception applying).
Patent Term Implications for CIP Applications
Under the Uruguay Round Agreements Act (URAA) (35 U.S.C. § 154(a)(2)), utility patent term is 20 years from the earliest nonprovisional filing date claimed under 35 U.S.C. § 120.
In a CIP application:
The 20-year patent term clock for the ENTIRE CIP patent begins running on the filing date of the parent nonprovisional application (Date A).
Consequently, claims drawn to new matter receive the later CIP filing date (Date C) for prior art examination, BUT their patent term expires 20 years from the earlier parent filing date (Date A).
Commercial Impact of Shortened Term
This creates a "worst of both worlds" scenario for new-matter claims in a CIP: they do not get the benefit of the parent's filing date to defeat prior art, but they suffer a shortened term because their patent expires 20 years from the parent filing date. For this reason, practitioners often choose to file a separate, standalone nonprovisional application for major new improvements rather than a CIP, unless maintaining an explicit continuity chain is paramount.